Clinical diabetes : a publication of the American Diabetes Association

Screening and Drug Treatment for Long-Term Kidney Disease in People with Type 2 Diabetes

Updated

Abstract

Primary care physicians recommend early and regular screening for chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D).

  • CKD screening should utilize both estimated glomerular filtration rate and urinary albumin-to-creatinine ratio testing.
  • The Kidney Disease: Improving Global Outcomes heatmap should be reviewed annually to assess CKD risk.
  • Lifestyle modifications are foundational for reducing CKD risk in individuals with T2D.
  • A combination of medications, including renin-angiotensin system inhibitors and sodium-glucose cotransporter 2 inhibitors, is suggested for managing CKD in T2D patients.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

E.E.W. is on the speakers’ bureau for Abbott Diabetes, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, and Sanofi; is on the advisory boards of Abbott Diabetes, Bayer, Boehringer Ingelheim, Eli Lilly, Medtronic, and Sanofi; is a consultant for Abbott Diabetes, Bayer, Boehringer Ingelheim, and Eli Lilly; and is an associate editor of Clinical Diabetes. A.C. is an advisor on scientific boards for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and Novo Nordisk; lectures for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Esteve, Janssen, Merck Sharp & Dohme, Mundipharma, and Novo Nordisk; and conducts research activities for AstraZeneca, Eli Lilly, Merck Sharp & Dohme, Mundipharma, and Novo Nordisk. D.N. is a member of advisory boards for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk; has moderating and speaking engagements for AstraZeneca, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk; has participated in research in the FINE-REAL and Pioneer REAL trials; and is a member of the Diabetes Canada Guidelines Steering Committee, Canadian Cardiovascular Society Lipid Guideline Panel, and St. Paul’s Hospital Continued Medical Education Committee. No other potential conflicts of interest relevant to this article were reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free